Cardiac AI Monitoring And Diagnostics Market Report 2026

Cardiac AI Monitoring And Diagnostics Market Overview

• Cardiac AI Monitoring And Diagnostics market size has reached to $2.14 billion in 2025 • Expected to grow to $6.94 billion in 2030 at a compound annual growth rate (CAGR) of 26.5% • Growth Driver: Role Of Cardiac AI Monitoring And Diagnostics In Addressing The Rising Prevalence Of Cardiovascular Diseases • Market Trend: Revolutionizing Cardiac Care Advancements In Artificial Intelligence-Based Implantable Cardiac Monitors • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac AI Monitoring And Diagnostics Market?

Cardiac AI monitoring and diagnostics refer to the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This involves the use of advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs). The main types of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics refers to the methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others by end users such as hospitals, diagnostic centers, and others.

What Is The Cardiac AI Monitoring And Diagnostics Market Growth Forecast?

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $6.94 billion in 2030 at a compound annual growth rate (CAGR) of 26.5%. The growth in the forecast period can be attributed to increasing adoption of ai-driven diagnostic tools, rising demand for remote patient monitoring solutions, expansion of personalized cardiac care, growing integration of ai with imaging and biomarkers, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of AI-based ecg interpretation, growing deployment of remote cardiac monitoring platforms, rising use of predictive analytics in cardiology, expansion of wearable AI-enabled cardiac devices, enhanced integration of multimodal cardiac data.

Global Cardiac AI Monitoring And Diagnostics Market Segmentation

1) By Function: Cardiac Diagnostics, Cardiac Monitoring 2) By Product: Software, Hardware 3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias 4) By End Users: Hospitals, Diagnostic Centers, Other End Users Subsegments: 1) By Cardiac Diagnostics: ECG Analysis, Echocardiography Analysis, Cardiac Imaging 2) By Cardiac Monitoring: Wearable Cardiac Monitors, Remote Patient Monitoring Systems, Implantable Cardiac Devices, Continuous ECG Monitoring Systems

What Is The Driver Of The Cardiac AI Monitoring And Diagnostics Market?

The growing prevalence of cardiovascular diseases is expected to propel the growth of cardiac AI monitoring and diagnostics going forward. Cardiovascular diseases (CVDs) are a set of illnesses of the heart and blood arteries, comprising cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. Cardiac AI monitoring and diagnostics help in early diagnosis, risk assessment, and tailored therapy of cardiovascular illnesses, resulting in better patient outcomes. For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, the growing prevalence of cardiovascular diseases is driving the cardiac AI monitoring and diagnostics industry.

Key Players In The Global Cardiac AI Monitoring And Diagnostics Market

Major companies operating in the cardiac ai monitoring and diagnostics market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

Global Cardiac AI Monitoring And Diagnostics Market Trends and Insights

Major companies operating in the cardiac AI monitoring and diagnostics market are focused on developing technology-based medical devices, such as artificial intelligence-based implantable cardiac monitors, to strengthen their position in the market. Artificial intelligence-based implantable cardiac monitors are devices that constantly track cardiac function. For instance, in May 2023, Biotronik, a Germany-based cardiovascular biomedical research and technology company, announced that the US Food and Drug Administration (FDA) had approved the BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV implantable cardiac monitor (ICM) uses BIOTRONIK's innovative, AI-powered SmartECG algorithm, which contains advanced algorithms that eliminate 86% of all false identifications while maintaining 98% of real episodes. This revolutionary technology improves detection accuracy for healthcare professionals, minimizing false positive warnings and assisting them in making quick and precise diagnoses of certain cardiac problems. Aside from SmartECG technology, BIOMONITOR IV is the first ICM to distinguish between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).

What Are Latest Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market?

In June 2024, Anumana, a US-based cardiac diagnostics company, formed a collaboration with InfoBionic.Ai to advance AI-powered remote cardiac telemetry technology. The partnership aims to enable early detection of cardiac diseases, improve patient monitoring and outcomes, and drive innovation in cardiac healthcare solutions. InfoBionic.Ai is a US-based technology company specializing in artificial intelligence solutions for remote cardiac monitoring and diagnostics.

Regional Outlook

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac AI Monitoring And Diagnostics Market?

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiac AI Monitoring And Diagnostics Market Report 2026?

The cardiac ai monitoring and diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac ai monitoring and diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.